Etavopivat
- Generic Name
- Etavopivat
- Drug Type
- Small Molecule
- Chemical Formula
- C22H23N3O6S
- CAS Number
- 2245053-57-8
- Unique Ingredient Identifier
- V4E0A9M44Q
Overview
Etavopivat is a small molecule activator of erythrocyte pyruvate kinase (PKR) under investigation for the treatment of sickle cell disease.
Background
Etavopivat is a small molecule activator of erythrocyte pyruvate kinase (PKR) under investigation for the treatment of sickle cell disease.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath